Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03729336 · ClinicalTrials.gov registry record · NA

PEEZY Midstream Urine Device Compared to Catheterized Urine Sample

A NA study, sponsored by Baylor Research Institute.

Completed
Registry status
NA
Development phase
74
Enrollment target

NCT03729336: Completed NA study, sponsored by Baylor Research Institute.

NCT03729336 is a NA study that has completed, run by Baylor Research Institute. The registered enrollment target is 74 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03729336, a NA study, has completed, sponsored by Baylor Research Institute.

COMPLETED
Registry status
NA
Development phase
74 participants
Enrollment target

Study Summary

Urine culture and microscopic urinalysis will be compared between 2 collection methods: PEEZY midstream urine collection, and urethral catheter collection.

Primary Outcome

Contamination defined as: presence of urethral or vaginal flora on urine culture OR epithelial cell presence in urinalysis

Interventions

  • DEVICE Midstream urine collection device
  • DEVICE Catheter for urine collection

Trial Details

FieldValue
Enrollment Target 74 participants
Start Date 2019-02-06
Est. Completion 2019-06-01
Phase NA
Baylor Research Institute

180 total trials

What the finished NCT03729336 record still lists

NCT03729336 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 74 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).

The record links to 0 conditions, and to 2 interventions - of which Midstream urine collection device is the first listed.

NCT03729336 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03729336 about?

NCT03729336 is a clinical study titled "PEEZY Midstream Urine Device Compared to Catheterized Urine Sample". Urine culture and microscopic urinalysis will be compared between 2 collection methods: PEEZY midstream urine collection, and urethral catheter collection.

What is the current status of trial NCT03729336?

This trial is currently completed. It is a NA study. The enrollment target is 74 participants. The study started on 2019-02-06. Estimated completion is 2019-06-01.

What interventions are being tested in trial NCT03729336?

The interventions under investigation include: Midstream urine collection device (DEVICE), Catheter for urine collection (DEVICE).

Who is sponsoring clinical trial NCT03729336?

This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03729336's enrollment target sits among peer trials

74 1082nd of 2000 higher than 912 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03422731 · 74 participants · Early Phase 1

    Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy

  • NCT03804853 · 74 participants · NA

    Rehabilitation Following Reverse Total Shoulder Arthroplasty

  • NCT04065776 · 74 participants · NA

    Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma

  • NCT04771156 · 74 participants · Phase 4

    Ketorolac in Palatoplasty

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03729336, the US trial registry maintained by the National Library of Medicine. NCT03729336 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.